Cargando…

Tamoxifen evolution

Detalles Bibliográficos
Autores principales:	Howell, A., Howell, S. J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9938251/ https://www.ncbi.nlm.nih.gov/pubmed/36765172 http://dx.doi.org/10.1038/s41416-023-02158-5

Ejemplares similares

Tamoxifen resistance and adjuvant hormone therapy
por: Howell, A
Publicado: (2005)

Should aromatase inhibitors be used as initial adjuvant treatment or sequenced after tamoxifen?
por: Cuzick, J, et al.
Publicado: (2006)

Effect of tamoxifen upon cell DNA analysis by flow cytometry in primary carcinoma of the breast.
por: Baildam, A. D., et al.
Publicado: (1987)

Tamoxifen delays the development of resistance to cisplatin in human melanoma and ovarian cancer cell lines.
por: McClay, E. F., et al.
Publicado: (1994)

The effect of anastrozole on the pharmacokinetics of tamoxifen in post-menopausal women with early breast cancer
por: Dowsett, M, et al.
Publicado: (1999)

Effect of tamoxifen on Ki67 labelling index in human breast tumours and its relationship to oestrogen and progesterone receptor status.
por: Clarke, R. B., et al.
Publicado: (1993)

Tamoxifen related side effects and their impact on breast cancer incidence: A retrospective analysis of the randomised IBIS-I trial
por: Hale, Michael J., et al.
Publicado: (2020)

Vertebrate Genome Evolution in the Light of Fish Cytogenomics and rDNAomics
por: Symonová, Radka, et al.
Publicado: (2018)

The evolution of prenatal care delivery guidelines in the United States
por: Peahl, Alex F., et al.
Publicado: (2021)

Tamoxifen for prevention of breast cancer: extended long-term follow-up of the IBIS-I breast cancer prevention trial
por: Cuzick, Jack, et al.
Publicado: (2015)

Uptake of tamoxifen in consecutive premenopausal women under surveillance in a high-risk breast cancer clinic
por: Donnelly, L S, et al.
Publicado: (2014)

The evolution of treatment for early breast cancer: what’s next?
por: Howell, T
Publicado: (2009)

A controlled trial of adjuvant tamoxifen, with or without prednisolone, in post-menopausal women with operable breast cancer.
por: Fentiman, I. S., et al.
Publicado: (1994)

The effect of tamoxifen on the genital tract
por: Polin, Sandra A., et al.
Publicado: (2008)

Pharmacogenomics Guided-Personalization of Warfarin and Tamoxifen
por: Wigle, Theodore J., et al.
Publicado: (2017)

Precautions for Patients Taking Tamoxifen
por: Heery, Mary, et al.
Publicado: (2018)

African ecology and human evolution /
por: Howell, F. Clark (Francis Clark)
Publicado: (1963)

The Effects of Tamoxifen on Tolerogenic Cells in Cancer
por: Mohd Idris, Ros Akmal, et al.
Publicado: (2022)

Tamoxifen Resistance: Emerging Molecular Targets
por: Rondón-Lagos, Milena, et al.
Publicado: (2016)

Tamoxifen and oxidative stress: an overlooked connection
por: Ahmed, Nermin S., et al.
Publicado: (2021)

Tamoxifen for women at high risk of breast cancer
por: Nazarali, Safia A, et al.
Publicado: (2014)

Effects of Pharmacogenetics on the Pharmacokinetics and Pharmacodynamics of Tamoxifen
por: de Vries Schultink, Aurelia H. M., et al.
Publicado: (2015)

Relationships between CYP2D6 phenotype, breast cancer and hot flushes in women at high risk of breast cancer receiving prophylactic tamoxifen: results from the IBIS-I trial
por: Sestak, I, et al.
Publicado: (2012)

CYP2D6 genotype affects outcome in postmenopausal breast cancer patients treated with tamoxifen monotherapy
por: Thompson, AM, et al.
Publicado: (2010)

IARC on tamoxifen.
Publicado: (1996)

Tumorigenic Effects of Tamoxifen on the Female Genital Tract
por: Nasu, Kaei, et al.
Publicado: (2008)

Epigenetic Mechanisms of Tamoxifen Resistance in Luminal Breast Cancer
por: Abdel-Hafiz, Hany A.
Publicado: (2017)

Mammographic density change in a cohort of premenopausal women receiving tamoxifen for breast cancer prevention over 5 years
por: Brentnall, Adam R., et al.
Publicado: (2020)

Resuming Sensitivity of Tamoxifen-Resistant Breast Cancer Cells to Tamoxifen by Tetrandrine
por: Wang, Yuntao, et al.
Publicado: (2021)

Chemoprevention: beyond tamoxifen
por: Cuzick, J
Publicado: (2005)

Effects of cyclin D(1 )gene amplification and protein expression on time to recurrence in postmenopausal breast cancer patients treated with anastrozole or tamoxifen: a TransATAC study
por: Lundgren, Katja, et al.
Publicado: (2012)

The importance of selection in the evolution of blindness in cavefish
por: Cartwright, Reed A., et al.
Publicado: (2017)

Type 2 inflammation and biological therapies in asthma: Targeted medicine taking flight
por: Howell, Imran, et al.
Publicado: (2023)

Tamoxifen and Ovarian Function
por: Berliere, Martine, et al.
Publicado: (2013)

Tamoxifen-associated vasculitis in a breast cancer patient
por: Candelaria, Myrna, et al.
Publicado: (2007)

Tamoxifen non-estrogen receptor mediated molecular targets
por: Bogush, Tatiana, et al.
Publicado: (2012)

Molecular mechanisms and mode of tamoxifen resistance in breast cancer
por: Ali, Shazia, et al.
Publicado: (2016)

Tamoxifen and Endometrial Cancer: A Janus-Headed Drug
por: Emons, Günter, et al.
Publicado: (2020)

A Role for Estrogen Receptor Phosphorylation in the Resistance to Tamoxifen
por: de Leeuw, Renée, et al.
Publicado: (2011)

Quantitative Approach to Fish Cytogenetics in the Context of Vertebrate Genome Evolution
por: Borůvková, Veronika, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5p4qivv341mtqukq16vh16i1dc